Epidermal Growth Factor Receptor (EGFR) plays a critical role in the development of several cancers. Thus, modulation/inhibition of EGFR activity is an appealing target of developing novel cancer ...
Despite extensive PI3K/AKT/mTOR inhibitor development efforts, only a limited number of compounds have been approved by the US Food and Drug Administration (FDA) (Table 1). The mechanistic target of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results